Disease Info Card

Urinary Bladder Calculi (disorder)

Information about Urinary Bladder Calculi (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Urinary Bladder Calculi (disorder)

Most recent studies have shown that Urinary Bladder Calculi (disorder) shares some biological mechanisms with bladder-neoplasm, carcinoma, cholecystolithiasis, cystitis, gall-bladder-diseases, hyperplasia, infective-disorder, kidney-calculi, lithiasis, malignant-neoplasms, neoplasms, neurogenic-urinary-bladder, prostatic-hyperplasia, stenosis, ureteral-calculi, urethral-diseases, urinary-bladder-diseases, urinary-incontinence, urinary-tract-infection, urolithiasis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Urinary Bladder Calculi (disorder), and have been seen in publications frequently: Aging, Cell Cycle, Cell Proliferation, Coagulation, Dehiscence, Diuresis, Enucleation, Excretion, Hemostasis, Inflammatory Response, Innervation, Intestinal Absorption, Localization, Micturition, Ossification, Pathogenesis, Reflex, Regeneration, Secretion, Transposition

Quite a number of genes have been found to play important roles in Urinary Bladder Calculi (disorder), such as ALB, CAT, CIC, CLIP1, CLIP2, CRAT, GLYAT, HMOX1, KLK3, NPEPPS, NPRL3, PCNA, PLAG1, POMC, PROS1, PSAT1, RANGAP1, SLC17A5, UMOD. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.